Russell Frank Company
OCAT

Russell Frank Company’s OCATA THERAPEUTICS, INC. COMMON STOCK OCAT Stock Holding History

Russell Frank Company’s Portfolio OCAT Stock Details OCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-72,372
Closed -$302K – 3108
2015
Q3 		$302K Buy
+72,372
New +$316K ﹤0.01% 2627

Other funds holding OCAT

AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Gabelli Funds
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
Magnetar Financial
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock Fund Advisors
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $449M AUM 51.52% 1-Year Est. Return
BlackRock Institutional Trust
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
OMERS Administration Corp
OMERS Administration Corp Toronto, Ontario, Canada $16.7B AUM 35.95% 1-Year Est. Return
Commonwealth of Pennsylvania Public School Employees Retirement System
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Russell Frank Company's OCAT Position: Q4 2015 in Review

Russell Frank Company sold out of OCATA THERAPEUTICS, INC. COMMON STOCK (OCAT) in Q4 2015, closing a stake of 72,372 shares — an estimated $302K sold.

Russell Frank Company first reported a position in OCAT in Q3 2015 and held it in 1 quarter. The position peaked at $302K in Q3 2015. 77 funds tracked by Wall St. Rank hold OCAT as of Q4 2015.

  • Russell Frank Company reported no remaining OCATA THERAPEUTICS, INC. COMMON STOCK position as of Q4 2015 after selling out during the quarter.
  • Russell Frank Company sold 72,372 OCATA THERAPEUTICS, INC. COMMON STOCK shares in Q4 2015, an estimated $302K.
  • Russell Frank Company first reported a position in OCATA THERAPEUTICS, INC. COMMON STOCK in Q3 2015 and held it in 1 quarter.
  • Russell Frank Company's OCATA THERAPEUTICS, INC. COMMON STOCK position peaked at $302K in Q3 2015.
  • 77 funds tracked by Wall St. Rank held OCATA THERAPEUTICS, INC. COMMON STOCK as of Q4 2015.

Based on Russell Frank Company's 13F filing for Q4 2015, filed 27 Jan 2016.